Document is current

Article History

Received: 4 June 2024

First Online: 6 August 2024

Declarations

:

: Authors declare no conflicts of interest regarding this article. Keizo Kanasaki Lecture Fees: Boehringer Ingelheim Japan, Eli Lilly Japan, Astellas, Novo Nordisk Pharma, Mitsubishi Tanabe, Daiichi Sankyo, Sanofi, Sumitomo Pharma, Kowa, Kyowa,Kirin, Taisho, AstraZeneca, Bayer Collaboration: Boehringer Ingelheim Japan, Boehringer-Ingelheim (Germany), Taisho, Kowa Research support: Boehringer Ingelheim Japan, Kowa, Nipro, Life Scan Masaomi Nangaku Lecture Fees: Kyowa Kirin, Mitsubishi Tanabe, Bayer, Astellas, JT, AstraZeneca Manuscript Fees: Kyowa Kirin Collaboration: JT Research support: Kyowa Kirin, Mitsubishi Tanabe, Chugai, Boehringer Ingelheim Japan, Torii, Takeda, Daiichi Sankyo Kohjiro Ueki Lecture Fees: Sumitomo Pharma, Novo Nordisk Pharma, Taisho, Eli Lilly Japan, Abbott Japan, Bayer, Boehringer Ingelheim Japan, Kowa, Daiichi Sankyo Collaboration: Sumitomo Pharma, Boehringer Ingelheim Japan, Eli Lilly Japan, Novo Nordisk Pharma, Sanofi Research support: Sumitomo Pharma, Boehringer Ingelheim Japan, Takeda, Mitsubishi Tanabe, Daiichi Sankyo, Kyowa Kirin, Ono Pharmaceutical, Novo Nordisk Pharma.

: This article does not contain any studies with human or animal subjects performed by any of the authors.